Pyxis Oncology Files 8-K on Shareholder Matters
Ticker: PYXS · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1782223
| Field | Detail |
|---|---|
| Company | Pyxis Oncology, Inc. (PYXS) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
TL;DR
Pyxis Oncology filed an 8-K for shareholder votes. Keep an eye on governance.
AI Summary
Pyxis Oncology, Inc. filed an 8-K on June 18, 2025, to report on the submission of matters to a vote of its security holders. The filing details the company's corporate structure, including its state of incorporation (Delaware) and principal executive offices located at 321 Harrison Avenue, Boston, MA.
Why It Matters
This filing indicates that Pyxis Oncology is engaging with its shareholders on important corporate decisions, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural and relates to standard corporate governance matters, not a significant event like a merger or financial distress.
Key Numbers
- 001-40881 — SEC File Number (Identifies the company's filing history with the SEC.)
- 83-1160910 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pyxis Oncology, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 321 Harrison Avenue, Boston, MA (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Pyxis Oncology's security holders?
The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported is June 18, 2025, which is also the date of the report.
What is Pyxis Oncology's primary business classification according to the filing?
Pyxis Oncology, Inc. is classified under Standard Industrial Classification code 2834, which is Pharmaceutical Preparations.
Where are Pyxis Oncology's principal executive offices located?
The principal executive offices are located at 321 Harrison Avenue, Boston, Massachusetts, 02118.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Pyxis Oncology, Inc. (PYXS).